IL6 and breast cancer: Many cytokine and growth factor receptors trigger JAK1/2-STAT3/5 activation, however, it was somewhat unexpected and striking that a GPCR such as DOR could also activate STAT3 in breast cancer cells to a similar extent as IL-6 cytokine stimulation (Fig. 3A).